States subpoena J&J information
This article was originally published in The Tan Sheet
Johnson & Johnson reveals multiple state attorneys general are seeking documents related to the April McNeil Consumer Healthcare recalls of Children's Tylenol and other pediatric liquid OTCs. Company officials said during a recent earnings call that the U.S. Attorney's Office for the Eastern District of Pennsylvania issued a grand jury subpoena related to the McNeil recalls (1"The Tan Sheet" July 26, 2010). The company said Aug. 11 in its fiscal 2010 second-quarter Security Exchange Commission filing that it has received civil investigative demands from other states as well. The firm does not expect the legal proceedings to adversely impact its financial condition
You may also be interested in...
McNeil Recalls Cut J&J's Profits, Draw U.S. Attorney's Subpoena
Investment analysts are confident in Johnson & Johnson's long-term viability even though recalls of OTC drugs and the temporary closure of the facility where the products were made prompted the firm to slash full-year profits estimates and triggered a federal investigation
ImmunoGen’s Elahere Data In Avastin-Naïve Ovarian Cancer Prompt Discussion About Earlier Use
The presenter on the MIRASOL study called the data “practice changing,” while the discussant cited Sutro’s STRO-002 as a potential option for patients with low folate receptor alpha expression.
ASCO - Servier’s Vorasidenib Puts The Brakes On Brain Cancer In INDIGO
Servier’s targeted therapy, vorasidenib, can effectively delay the need for more drastic treatment in patients with low-grade glioma, but increases in liver enzymes including two cases of Hy’s law have cast some shade over the INDIGO data.